Neoral

基本解釋

The relative bioavailability of CyA HP50 and CyA HP55 nanoparticles calculated by the AUC 0-72 were 82 3% and 119 6%, bioequivalent to the reference of Neoral.
與Neoral相比 ,CyA HP5 0NP與CyA HP5 5NP的相對(duì)生物利用度分別為 82 3%25和 1 1 9 6%25 ,均無(wú)顯著性差異 ;
Compared with the Neoral microemulsion,the relative bioavailability of CyA was 94.8%,115.2%,113.6% and 132.5% for CyA-E100,CyA-L100,CyA-L100-55 and CyA-S100 nanoparticles respectively.
與Neoral微乳相比; CyA E100;CyA L100;CyA L100 55和CyA S100納米粒的相對(duì)生物利用度分別為94.;8%25;115
CyA-S100 nanoparticles was shown to significantly improve the oral bioavailability of CyA compared with Neoral microemulsion ( P 經(jīng)統(tǒng)計(jì)分析;CyA S100納米粒可以顯著改善CyA的生物利用度(P
Neoral C2 monitoring in Chinese renal transplantation recipients
國(guó)人腎移植術(shù)后微乳化環(huán)孢素血藥濃度C2監(jiān)測(cè)的臨床意義
Analysis of variability of drug exposure and blood concentration during Neoral absorption phase in Chinese adult liver transplant recipients
Neoral吸收期血藥濃度和藥物暴露量在中國(guó)成人肝移植受體中的變異性分析